Budesonide ER Capsules
ID: SPE2D2-25-R-0008Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for the procurement of Budesonide ER Capsules, specifically 3MG capsules, under Solicitation No. SPE2D2-24-R-0013. This procurement aims to secure pharmaceutical products that are critical for various medical applications within military and defense health systems. Proposals must be submitted electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS), adhering to specific contract obligations including delivery schedules, product registration, and compliance with federal acquisition regulations. Interested parties can contact Christopher Newman at christopher.newman@dla.mil or Jason Wray at jason.wray@dla.mil for further information regarding the solicitation process.

    Files
    Title
    Posted
    The document outlines Solicitation No. SPE2D2-24-R-0013, which pertains to a federal request for proposals (RFP) for the procurement of pharmaceutical products, specifically Budesonide ER 3MG Capsules. It details submission instructions for offers via the Defense Logistics Agency Internet Bid Board System (DIBBS), emphasizing the necessity of electronic proposals. The solicitation includes a comprehensive Statement of Work, specifying contract obligations including delivery schedules, product registration, labeling requirements, and compliance with various federal acquisition regulations. The document highlights critical contract clauses such as FAR 52.212-4 regarding terms and conditions for commercial items, and DFARS clauses prohibiting certain telecommunications equipment from covered foreign countries. It also mandates the submission of a subcontracting plan for large businesses and outlines a reporting system for contractor performance evaluations. Furthermore, the RFP includes stipulations for compliance with federal laws concerning ethics, labor standards, and trade agreements. Overall, the solicitation aims to ensure accountability and integrity while promoting compliance with federal guidelines in the acquisition processes for pharmaceutical supplies, reinforcing the government’s commitment to ethical procurement practices.
    The government file entails various requests for proposals (RFPs) and grant opportunities within federal, state, and local realms, though most content is garbled and lacks coherent information. The overarching theme appears to focus on funding mechanisms and requirements outlined for potential applicants seeking financial support for projects aligned with governmental goals. The document typically includes essential elements such as eligibility criteria, application timelines, and specific project objectives needed for compliance with funding guidelines. The fragmented nature of the document makes it difficult to extract precise details, but it seemingly emphasizes the importance of adhering to specified standards to secure grants. It also suggests a collaborative approach, encouraging partnerships among various stakeholders involved in proposal submissions, thereby highlighting aspects of transparency and adherence to procedural mandates. Ultimately, the document reflects the government's intent to allocate resources for initiatives that foster community development and regulatory compliance, although much of the specific information appears lost or corrupted. Further reviews or supplementary documents are necessary to gain a clearer understanding of the underlying objectives and particulars present in the RFPs and grant opportunities.
    The document appears to be corrupted or encoded improperly, making it unreadable and unsuitable for summarization. A standard analysis of the structure, main topics, and key ideas typical of government RFPs, federal grants, and state/local RFPs cannot be performed. To achieve an accurate summary, clarity of the content is needed, including complete sentences and coherent text. Without this, a substantive understanding of the document's intention or objectives cannot be extracted.
    Lifecycle
    Title
    Type
    Budesonide ER Capsules
    Currently viewing
    Presolicitation
    Similar Opportunities
    Metaxalone Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for the supply of Metaxalone 800 MG tablets, available in 100-count and 500-count bottles. This procurement aims to establish a requirements contract with estimated annual quantities for a base year and four option years, emphasizing the need for compliance with various federal acquisition regulations and ethical standards. Metaxalone is a critical medication used for muscle relaxation, making this contract vital for supporting military health services. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) between November 7 and December 7, 2025, by 3:00 PM EST. For further inquiries, contact Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil.
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for Trazodone HCL tablets in various dosages and bottle counts. This procurement aims to fulfill substantial pharmaceutical supply needs, emphasizing compliance with technical and quality requirements as outlined in the solicitation documents. The solicitation, identified as SPE2D2-26-R-0003, mandates electronic submissions via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries.
    Rabeprazole Sodium Delayed Release Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    Metformin HCL
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is planning to issue a national requirements contract for Metformin HCL ER. The contract will establish a national supply source to provide Metformin HCL ER Tablets in various quantities and bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The solicitation will be posted on DLA Bid Board System (DIBBS) and Sam.gov. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is August 2021.
    DLA MedSurg Prime Vendor Gen VI
    Dept Of Defense
    The Defense Logistics Agency (DLA) is seeking proposals for the Medical Surgical Prime Vendor (Med/Surg PV) Program, which aims to provide medical and surgical supplies across three Global Regions: North, South, and West. This procurement involves awarding Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for both Primary and Backup vendors, facilitating the delivery of a wide range of commercially available medical supplies to various military and federal healthcare facilities. The program is crucial for ensuring that Medical Treatment Facilities (MTFs) and operational customers have timely access to essential medical products, thereby supporting military readiness and healthcare operations. Interested vendors must submit their proposals electronically via the DLA Internet Bid Board System (DIBBS) by January 8, 2026, at 3:00 PM Local Philadelphia Time, and can direct inquiries to Beatrice Lopez-Pollard at beatrice.lopez-pollard@dla.mil or Joshua Tankel at Joshua.Tankel@dla.mil.
    Ibuprofen 400MG/600MG/800MG Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ibuprofen 400MG/600MG/800MG Tablets. The contract will establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is March of 2023.
    81--BAG,ROLLPACK,MEDICA
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of 57 medical roll pack bags (NSN 8145015485287). This solicitation is part of a total small business set-aside and aims to secure containers essential for military logistics and troop support. The selected vendor will be responsible for delivering the specified quantity to DLA Distribution San Joaquin within 133 days after award. Interested parties must submit their quotes electronically, and any inquiries should be directed to the buyer via email at DibbsBSM@dla.mil.
    65--ADMINISTRATION SET,
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking quotes for the procurement of administration sets, specifically NSN 6515015616204. The requirement includes two lines: 58 units for Line 0001 and 148 units for Line 0002, both to be delivered to the DLA Distribution San Joaquin within 48 days after order (ADO). These medical supplies are critical for various healthcare applications within military operations. Interested vendors must submit their quotes electronically, as hard copies of the solicitation will not be available, and any inquiries should be directed to the buyer via email at DibbsBSM@dla.mil.
    Reactive and Inactive Skin Decontamination Lotion
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking procurement for Reactive and Inactive Skin Decontamination Lotion (RSDL/ISDL). This contract involves the acquisition of specialized drugs and biologicals designed for decontaminating skin exposed to hazardous substances, which is critical for the safety and protection of military personnel in various operational environments. The opportunity is detailed in a redacted Justification and Approval document, indicating the importance of these products in maintaining troop readiness and safety. Interested vendors can reach out to Myrna I. Rodriguez at Myrna.Rodriguez@dla.mil or call 215.737.4711 for further information regarding this procurement.